TNON · Tenon Medical, Inc.
$3.70
+0.00 (+0.00%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about the Company's ability to continue as a going concern for one year after the date that these financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.09M
Shares
667,047
Volume · Oct 6
113.18K
Avg daily vol (40 sessions)
10.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.70
Open$3.55
Day$3.52–3.82
52W close$2.44–45.15
Avg vol 30d11.5M
Short int539K · 80.8% float · 1.0d
Short vol41%
Last earningsAug 13, 2026
DataApr 2022–Oct 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 14, 2026
Est · unconfirmed
· in 6 wks
filed Aug 13, 2026
call held Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$5.31M
Trailing 12 months
Net income (TTM)
−$13.70M
Trailing 12 months
Revenue growth YoY
+126.8%
Year over year
Operating margin
-242.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+51.2%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
80.8%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−82%
below
Price vs 50-day avg
−27%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
3%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−87%
trailing
YTD return
−89%
this year
Relative strength
−99%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $20 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +2 funds added
Insider flow
Distributing
Net -$105.4K over 90 days · 50% sells
Short interest
Rising
80.85% of float · ▲ +314.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
22 holders — mid 3-yr range
Squeeze score
59
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
60%
expanding
EPS growth
+85%
Y/Y
Free cash flow
$-11.0M
Quant / Vol
risk profile
Volatility
219%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
26.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the 8-K filed Feb 6, 2026
Revenue
· Full Year 2025
$3.91M – $3.94M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−82%
Bearish
Price vs 50-day avg
−27%
Bearish
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
3%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $20 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +2 funds added
Insider flow
Distributing
Net -$105.4K over 90 days · 50% sells
Short interest
Rising
80.85% of float · ▲ +314.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
22 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $4 · 3%
Range high $45
vs 200-day avg -82%
vs 50-day avg -27%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TNON
this stock
Tenon Medical, Inc.
|
$2.09M | — | +20.4% | — | 80.8% |
|
ABT
Abbott Laboratories
|
$174.90B | -20.1% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -8.4% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -18.8% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.5% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TNON | +29.4% | -0.5% | -87.1% | -9.5% | -88.9% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +28.2% | -1.1% | -98.7% | -11.1% | -102.5% |